QQ客服 官方微博 反馈留言

	Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF mutation
	Kai Wang; Yanrong Li; Na Song; Xiaofang Che; Kezuo Hou; Ling Xu; Ming Bai; Qiwei Wang; Yuanhe Wang; Yang Zhou
刊名	Journal of Cellular Biochemistry
	2019
卷号	Vol.120 No.4页码:5315-5325
关键词	apoptosis colon cancer proliferation signal transducer and activator of transcription 3 vemurafenib
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4739962
专题	湖南大学
作者单位	1.Department of Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China 2.Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China 3.Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
推荐引用方式 GB/T 7714	Kai Wang,Yanrong Li,Na Song,et al. Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF mutation[J]. Journal of Cellular Biochemistry,2019,Vol.120 No.4:5315-5325.
APA	Kai Wang.,Yanrong Li.,Na Song.,Xiaofang Che.,Kezuo Hou.,...&Jingdong Zhang.(2019).Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF mutation.Journal of Cellular Biochemistry,Vol.120 No.4,5315-5325.
MLA	Kai Wang,et al."Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF mutation".Journal of Cellular Biochemistry Vol.120 No.4(2019):5315-5325.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。